2330 W. Joppa Road
12 articles with Gliknik Inc.
Gliknik To Receive $15 Million Milestone Payment From Pfizer Inc. Following Clinical Progress With PF-06755347, Previously Known As GL-2045
Gliknik Inc. announced that it will receive a $15 million milestone payment from Pfizer Inc.
Patent covers uses of recombinant compounds with at least two human IgG1 Fc domains that bind receptors found on immune cells
Gliknik Inc. Announces Dosing Of First Patient In Phase II Trial Targeting Prevention Of Recurrence Of High-Risk Oral Cavity Cancer
Gliknik Inc. Announces Interim Clinical Data From Use of Its Immunomodulator Drug Candidate in Multiple Myeloma Patients
Published Preclinical Data Demonstrate Ability of Gliknik Inc.'s Recombinant Stradomers™ to Mimic Anti-Autoimmune Effect of IVIG
University of Maryland, Baltimore BioPark Signs Gliknik Inc. First Tenant in Its BioInnovation Center in Building Two